M. Mohri

440 total citations
10 papers, 384 citations indexed

About

M. Mohri is a scholar working on Hematology, Internal Medicine and Molecular Biology. According to data from OpenAlex, M. Mohri has authored 10 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Internal Medicine and 3 papers in Molecular Biology. Recurrent topics in M. Mohri's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Atrial Fibrillation Management and Outcomes (3 papers). M. Mohri is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Atrial Fibrillation Management and Outcomes (3 papers). M. Mohri collaborates with scholars based in Japan and United States. M. Mohri's co-authors include Donald Küfe, M. Sata, Takayuki Asano, David R. Spriggs, Satsuki Iwase, Hisashi Yamada, Gabriel Robbins, ML Sherman, K. Imamura and Cristina Rodrı́guez and has published in prestigious journals such as Blood, The Journal of Immunology and Diabetologia.

In The Last Decade

M. Mohri

10 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Mohri Japan 9 141 90 90 85 83 10 384
M. Sata Japan 10 149 1.1× 105 1.2× 29 0.3× 84 1.0× 90 1.1× 11 393
Noemi Michetti Italy 9 184 1.3× 123 1.4× 72 0.8× 33 0.4× 124 1.5× 11 612
Tiziana Spatola Italy 10 89 0.6× 61 0.7× 55 0.6× 26 0.3× 76 0.9× 12 423
Alf‐Åge R. Pettersen Norway 13 72 0.5× 233 2.6× 136 1.5× 74 0.9× 73 0.9× 22 485
Mengduan Liu China 7 90 0.6× 69 0.8× 77 0.9× 68 0.8× 66 0.8× 22 588
Monica Ahuja India 12 86 0.6× 239 2.7× 40 0.4× 109 1.3× 47 0.6× 16 547
A. M. Carter United Kingdom 6 114 0.8× 101 1.1× 61 0.7× 22 0.3× 95 1.1× 6 362
Cristina Razzari Italy 13 293 2.1× 93 1.0× 51 0.6× 107 1.3× 26 0.3× 21 547
Egle Incalcaterra Italy 13 40 0.3× 109 1.2× 80 0.9× 16 0.2× 52 0.6× 22 339
Peter Tschentscher Germany 7 29 0.2× 162 1.8× 135 1.5× 46 0.5× 125 1.5× 12 448

Countries citing papers authored by M. Mohri

Since Specialization
Citations

This map shows the geographic impact of M. Mohri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mohri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mohri more than expected).

Fields of papers citing papers by M. Mohri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mohri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mohri. The network helps show where M. Mohri may publish in the future.

Co-authorship network of co-authors of M. Mohri

This figure shows the co-authorship network connecting the top 25 collaborators of M. Mohri. A scholar is included among the top collaborators of M. Mohri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Mohri. M. Mohri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Moll, Stephan, Celeste Lindley, S Pescatore, et al.. (2004). Phase I study of a novel recombinant human soluble thrombomodulin, ART‐123. Journal of Thrombosis and Haemostasis. 2(10). 1745–1751. 61 indexed citations
2.
Mohri, M., et al.. (1999). The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.. PubMed. 82(6). 1687–93. 73 indexed citations
3.
Mohri, M., Makoto Oka, Yoshikazu Aoki, et al.. (1997). The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis). Blood Coagulation & Fibrinolysis. 8(5). 274–283. 51 indexed citations
4.
5.
Gabazza, Esteban C., Hiroyuki Takeya, Hiroshi Deguchi, et al.. (1996). Protein C activation in NIDDM patients. Diabetologia. 39(12). 1455–1461. 36 indexed citations
6.
Honda, Goichi, Charles Masaki, M Zushi, et al.. (1995). The Roles Played by the D2 and D3 Domains of Recombinant Human Thrombomodulin in Its Function. The Journal of Biochemistry. 118(5). 1030–1036. 9 indexed citations
8.
Yamada, Hisashi, Satsuki Iwase, M. Mohri, & Donald Küfe. (1991). Involvement of a nuclear factor-kappa B-like protein in induction of the macrophage colony-stimulating factor gene by tumor necrosis factor. Blood. 78(8). 1988–1995. 38 indexed citations
9.
Spriggs, D R, ML Sherman, K. Imamura, et al.. (1990). Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor.. PubMed. 50(22). 7101–7. 65 indexed citations
10.
Mohri, M., David R. Spriggs, & Donald Küfe. (1990). Effects of lipopolysaccharide on phospholipase A2 activity and tumor necrosis factor expression in HL-60 cells.. The Journal of Immunology. 144(7). 2678–2682. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026